Medical Marijuana Inc (OTCMKTS:MJNA) is a penny player in the cannabis patch that’s been on everyone’s radar for some time. The stock has been finding clear resistance overhead in the $0.15-0.20 area so far in 2017. Given that their PR machine has been very active, this isn’t a terrific sign for current shareholders. However, the company is more geographically diversified than its competition and has some new catalysts in play. The most recent key drivers for the company are two new items.
First is its announcement that its subsidiary, Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, held an exclusive Red-Carpet Event in Phoenix, Az., this weekend. The Red-Carpet Event provides a unique opportunity to network with top Kannaway leaders, the company’s executive team and fellow business owners. Secondly, its subsidiary HempMeds Brasil was featured in a Veja.com news article discussing that ANVISA permitted the